SuperworthSana Biotechnology shares outstanding SANA
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 295.7M
- On a year earlier
- +24.0%
- more shares
Sana Biotechnology had 295.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 24.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 275.9M | +17% |
| FY2024 | 236.3M | +20% |
| FY2023 | 197.3M | +4% |
| FY2022 | 190.4M | +3% |
| FY2021 | 184M | +1103% |
| FY2020 | 15.3M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 295.7M | +24% | |
| Q1 FY26 | 276.9M | +17% | |
| Q4 FY25 | 275.9M | +17% | |
| Q3 FY25 | 260.5M | +11% | |
| Q2 FY25 | 238.4M | +2% | |
| Q1 FY25 | 237.6M | +9% | |
| Q4 FY24 | 236.3M | +20% | |
| Q3 FY24 | 235.4M | +17% | |
| Q2 FY24 | 234.4M | +22% | |
| Q1 FY24 | 217.3M | +14% | |
| Q4 FY23 | 197.3M | +4% | |
| Q3 FY23 | 200.5M | +6% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Sana Biotechnology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.